The amount of money that biomedical researchers receive from drug companies outstrips grants from the federal government, $55 billion versus $36 billion, respectively, reports the Los Angeles Times. With this funding, drug companies build close relationships with universities and their researchers who still appear to be impartial as they serve on committees that pen tre

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Magdalena Skipper, the incoming editor-in-chief of Nature, speaks with NPR's Weekend Edition Sunday.

Genetic genealogy has led to an arrest in another cold case, dating back to 1987.

In PLOS this week: mutation in second gene widens clinical symptoms of people with ADD3 mutations, comparative genomic analysis of Pseudovibrio, and more.

Wired reports that 23andMe is trying to bolster its outside collaborations.